Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: What would PTSC see out of $50M?---boomer

So that's about 7c a share (say $28M on 400M shares and 28/400 = 0.07).

A nickel a share dividend would be real nice. :0)

Share
New Message
Please login to post a reply